Zelluna partners with Etcembly to advance AI-driven TCR engineering for solid tumours

IDEAYA Biosciences enrols first patient in Phase 1 trial of PRMT5 inhibitor IDE892

Servier signs definitive agreement with Day One Biopharmaceuticals

Foresee Pharmaceuticals receives positive CHMP opinion for CAMCEVI 21 mg

Great Novel Therapeutics' GNTbm-38 approved by US FDA for Phase I trial

Elicera Therapeutics reports complete metabolic responses in highest‑dose CARMA cohort

Akeso agrees clinical trial collaboration with INOVIO

Breckenridge Pharmaceutical launches Pomalidomide Capsules in US market

ValiRx establishes animal health subsidiary to target veterinary oncology market

Blue Earth Diagnostics reports positive results from comparator study of POSLUMA (flotufolastat F 18) and piflufolastat F 18 urinary bladder radioactivity

Novartis to build new radioligand therapy site in Texas

Epredia signs EU distribution deal with Mindpeak for AI pathology software

Astellas Pharma signs global strategic collaboration with Vir Biotechnology

Illumina sets out 18-Month NovaSeq X roadmap to boost sequencing performance and scale

Gilead to acquire Arcellx to gain full control of anito-cel